大塚ホールディングスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2023/02/27 | 4,137 | 4,150 | 4,115 | 4,146 | +1 | ±0% | 849,700 |
2023/02/24 | 4,121 | 4,147 | 4,067 | 4,145 | +15 | +0.4% | 1,342,600 |
2023/02/22 | 4,162 | 4,177 | 4,098 | 4,130 | -39 | -0.9% | 1,495,800 |
2023/02/21 | 4,150 | 4,169 | 4,129 | 4,169 | +5 | +0.1% | 941,600 |
2023/02/20 | 4,209 | 4,219 | 4,159 | 4,164 | -11 | -0.3% | 1,017,300 |
2023/02/17 | 4,179 | 4,197 | 4,162 | 4,175 | -32 | -0.8% | 1,455,600 |
2023/02/16 | 4,200 | 4,216 | 4,167 | 4,207 | +9 | +0.2% | 1,080,800 |
2023/02/15 | 4,197 | 4,294 | 4,188 | 4,198 | +11 | +0.3% | 1,362,500 |
2023/02/14 | 4,153 | 4,255 | 4,130 | 4,187 | +87 | +2.1% | 1,373,600 |
2023/02/13 | 4,121 | 4,134 | 4,090 | 4,100 | -37 | -0.9% | 637,400 |
2023/02/10 | 4,174 | 4,178 | 4,112 | 4,137 | +5 | +0.1% | 1,010,500 |
2023/02/09 | 4,117 | 4,142 | 4,105 | 4,132 | ±0 | ±0% | 625,700 |
2023/02/08 | 4,121 | 4,155 | 4,108 | 4,132 | +44 | +1.1% | 718,100 |
2023/02/07 | 4,107 | 4,137 | 4,080 | 4,088 | -32 | -0.8% | 763,600 |
2023/02/06 | 4,130 | 4,137 | 4,106 | 4,120 | +33 | +0.8% | 765,500 |
2023/02/03 | 4,101 | 4,134 | 4,084 | 4,087 | -28 | -0.7% | 788,600 |
2023/02/02 | 4,130 | 4,134 | 4,107 | 4,115 | -38 | -0.9% | 544,900 |
2023/02/01 | 4,188 | 4,193 | 4,140 | 4,153 | -5 | -0.1% | 687,800 |
2023/01/31 | 4,190 | 4,200 | 4,154 | 4,158 | -12 | -0.3% | 879,000 |
2023/01/30 | 4,159 | 4,183 | 4,152 | 4,170 | -12 | -0.3% | 687,200 |
2023/01/27 | 4,218 | 4,218 | 4,169 | 4,182 | -24 | -0.6% | 657,000 |
2023/01/26 | 4,242 | 4,256 | 4,201 | 4,206 | -20 | -0.5% | 665,300 |
2023/01/25 | 4,235 | 4,257 | 4,220 | 4,226 | +6 | +0.1% | 886,100 |
2023/01/24 | 4,189 | 4,237 | 4,175 | 4,220 | +55 | +1.3% | 1,038,900 |
2023/01/23 | 4,184 | 4,192 | 4,154 | 4,165 | +7 | +0.2% | 810,600 |
2023/01/20 | 4,155 | 4,158 | 4,128 | 4,158 | +28 | +0.7% | 957,700 |
2023/01/19 | 4,133 | 4,153 | 4,115 | 4,130 | -44 | -1.1% | 821,500 |
2023/01/18 | 4,088 | 4,177 | 4,060 | 4,174 | +96 | +2.4% | 1,389,600 |
2023/01/17 | 4,063 | 4,082 | 4,034 | 4,078 | +30 | +0.7% | 906,400 |
2023/01/16 | 4,015 | 4,064 | 4,011 | 4,048 | -9 | -0.2% | 757,900 |
2023/01/13 | 4,050 | 4,073 | 4,023 | 4,057 | -29 | -0.7% | 1,315,100 |
2023/01/12 | 4,091 | 4,104 | 4,068 | 4,086 | -1 | ±0% | 801,300 |
2023/01/11 | 4,057 | 4,103 | 4,056 | 4,087 | +45 | +1.1% | 1,024,200 |
2023/01/10 | 4,084 | 4,101 | 4,034 | 4,042 | -61 | -1.5% | 1,165,400 |
2023/01/06 | 4,099 | 4,128 | 4,089 | 4,103 | +3 | +0.1% | 783,000 |
2023/01/05 | 4,144 | 4,153 | 4,090 | 4,100 | -29 | -0.7% | 902,900 |
2023/01/04 | 4,251 | 4,257 | 4,129 | 4,129 | -176 | -4.1% | 970,200 |
2022/12/30 | 4,322 | 4,347 | 4,299 | 4,305 | -28 | -0.6% | 736,200 |
2022/12/29 | 4,354 | 4,359 | 4,292 | 4,333 | -71 | -1.6% | 792,000 |
2022/12/28 | 4,400 | 4,417 | 4,371 | 4,404 | +3 | +0.1% | 967,600 |
2022/12/27 | 4,421 | 4,435 | 4,401 | 4,401 | -7 | -0.2% | 562,900 |
2022/12/26 | 4,420 | 4,439 | 4,406 | 4,408 | -4 | -0.1% | 452,400 |
2022/12/23 | 4,421 | 4,445 | 4,387 | 4,412 | -31 | -0.7% | 905,100 |
2022/12/22 | 4,424 | 4,458 | 4,394 | 4,443 | +32 | +0.7% | 665,800 |
2022/12/21 | 4,427 | 4,446 | 4,398 | 4,411 | -39 | -0.9% | 834,800 |
2022/12/20 | 4,512 | 4,538 | 4,366 | 4,450 | -51 | -1.1% | 935,200 |
2022/12/19 | 4,504 | 4,523 | 4,484 | 4,501 | -32 | -0.7% | 786,000 |
2022/12/16 | 4,557 | 4,557 | 4,518 | 4,533 | -57 | -1.2% | 1,466,000 |
2022/12/15 | 4,602 | 4,645 | 4,589 | 4,590 | -22 | -0.5% | 593,000 |
2022/12/14 | 4,600 | 4,636 | 4,592 | 4,612 | +5 | +0.1% | 714,600 |
301~
350
件表示中 / 3284件
類似銘柄と比較する
現在ご覧いただいている「大塚HD」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
大塚HD | 650,500円 | +6.0% | +131.3% | 1.84% | 14.13倍 | 1.48倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
中外薬 | 503,600円 | -3.7% | +4.1% | 1.63% | 24.70倍 | 5.10倍 |
|
ロシュ傘下で成長続ける異色の医薬品大手。抗体・バイオで先行、抗がん剤、骨・関節領域に強い |
武 田 | 416,500円 | +2.0% | +4.2% | 4.71% | 112.66倍 | 0.90倍 |
|
国内製薬首位。がん、中枢神経、消化器、希少疾患等に重点。巨額買収で世界売上上位10強入り |
アステラス薬 | 151,100円 | +2.9% | +72.2% | 4.90% | 90.32倍 | 1.70倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
塩野義 | 714,400円 | +4.6% | +0.9% | 2.38% | 12.42倍 | 1.64倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
市場注目の銘柄
チャート関連のコラム